GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

 2,198.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,198.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,076.08m
  • Volume: 0
  • Market Cap: £89,592m
  • RiskGrade: 129
  • Beta: 0.86

Latest ShareCast News

Director dealings: GSK chairman raises stake

By Iain Gilbert

Date: Friday 06 Feb 2026

(Sharecast News) - GSK revealed on Friday that non-executive chairman Jonathan Symonds had acquired 2,500 ordinary shres in the FTSE 100-listed drugmaker.

GSK ShareCast News

EU gives GSK's Nucala green light for use in unc... 06-Feb-2026 ShareCast
GSK sees slower sales growth in 2026 as patent l... 04-Feb-2026 ShareCast
GSK to cut up to 350 R&D jobs across UK, US 02-Feb-2026 ShareCast
Citi starts AstraZeneca at 'buy', takes 'neutral... 27-Jan-2026 ShareCast
GSK vaccine given green light for all adults in ... 26-Jan-2026 ShareCast

GSK Regulatory News

Director/PDMR Shareholding 06-Feb-2026 10:30 RNS
Nucala COPD approved by the European Commission 06-Feb-2026 07:00 RNS
Director/PDMR Shareholding 05-Feb-2026 15:30 RNS
Final Results 04-Feb-2026 07:00 RNS
Total Voting Rights 02-Feb-2026 15:00 RNS

GSK Newspaper Links

GSK beats City expectations but forecasts softer... 04-Feb-2026 Times
GSK looking at future cost savings and manufactu... 02-Feb-2026 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 2,198.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 2,198.00
52 Week Low 1,264.00
Volume 0
Shares Issued 4,076.08m
Market Cap £89,592m
Beta 0.86
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 19-Feb-26 13-Nov-25
Paid 09-Apr-26 08-Jan-26
Amount 18.00p 16.00p

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

GSK Key Personnel

CEO Luke Miels

Top of Page